Tissue Regenix Group plc (LON:TRX – Get Free Report)’s stock price shot up 17.6% on Friday . The company traded as high as GBX 29.40 ($0.39) and last traded at GBX 29.40 ($0.39). 134,613 shares were traded during mid-day trading, an increase of 143% from the average session volume of 55,417 shares. The stock had previously closed at GBX 25 ($0.34).
Tissue Regenix Group Stock Performance
The business’s 50 day simple moving average is GBX 30.54 and its two-hundred day simple moving average is GBX 40.10. The firm has a market capitalization of £25.69 million, a PE ratio of -29.42 and a beta of 1.61. The company has a current ratio of 4.03, a quick ratio of 2.36 and a debt-to-equity ratio of 31.16.
Tissue Regenix Group Company Profile
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Recommended Stories
- Five stocks we like better than Tissue Regenix Group
- How to trade penny stocks: A step-by-step guide
- PepsiCo Bottomed Out—Time to Chugalug This Blue-Chip Buy?
- 3 Stocks to Consider Buying in October
- Is J.B. Hunt Stock a Sleeping Giant Heading Into 2026?
- How to Buy Cheap Stocks Step by Step
- These 3 Rare Earth Stocks Are Surging Alongside MP Materials
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
